Article Details

Phase I–II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor ...

Retrieved on: 2024-09-23 20:08:09

Tags for this article:

Click the tags to see associated articles and topics

Phase I–II study of OBI-888, a humanized monoclonal IgG1 antibody against the tumor .... View article details on hiswai:

Excerpt

Therefore, Globo H is a potential target for anticancer therapeutics, such as monoclonal antibodies and antibody-drug conjugates (ADCs) [ 2 ].

Article found on: www.springermedizin.de

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo